Thomas Ellison

Thomas Ellison, PhD has a strong background in research and development. Thomas has held various positions at different companies and institutions throughout their career. From 2017 to the present, they have served as the Director of Research & Development at Verndari, Inc., where they are responsible for overseeing and managing the research and development activities. Prior to this role, they worked at the University of Virginia Health System as a Postdoc in the Kedes Laboratory from 2008 to 2014. In this position, they conducted research on a specific topic. From 2000 to 2008, Ellison worked as a Graduate Student at UC Davis in the Hsing-Jien Kung Laboratory. Their research focused on investigating the role of K-bZIP, an early viral transcription factor of KSHV, in reactivation from latency. Ellison also characterized the histone modifications and association of K-bZIP and K-Rta with viral chromatin during KSHV reactivation. Earlier in their career, from 1997 to 1999, they held positions as a Postgraduate Researcher in the Dandekar Laboratory and as a Research Assistant in the Torres Laboratory, both at UC Davis. In these roles, they conducted various research projects related to vaccine development for HIV-1. Overall, Thomas Ellison, PhD has a strong background in research and development, with expertise in the field of virology and vaccine development.

Thomas Ellison, PhD completed their Bachelor of Science in Microbiology, General at UC Davis from 1994 to 1999. Thomas then pursued their Doctor of Philosophy in Microbiology, General at the same institution from 2000 to 2008.